首页 > 最新文献

Gastro hep advances最新文献

英文 中文
A Systematic Review and Meta-Analysis: Adverse Inflammatory Bowel Disease Outcomes Following Acute COVID-19
Pub Date : 2025-01-01 DOI: 10.1016/j.gastha.2024.10.021
Evangelin Shaloom Vitus , Simran Mann , Charlie W. Lees , Tine Jess , Rahma Elmahdi

Background and Aims

Respiratory viral infections have been implicated in the exacerbation of immune-mediated inflammatory diseases such as inflammatory bowel disease (IBD). To understand the impact of early SARS-CoV-2 variants on the risk of adverse IBD outcomes, we aimed to perform a meta-analysis of high-quality studies.

Methods

Cohort studies investigating adverse IBD outcomes (IBD flares, change in disease activity, change in medication, IBD-related hospitalization, and surgery) following COVID-19 were retrieved from MEDLINE and Embase. The Risk Of Bias In Nonrandomized Studies—of Exposure tool was used to assess risk of bias. Random effects model meta-analysis was used to calculate the hazard ratio (HR) for risk of adverse outcomes. Subgroup analysis was performed to estimate risk of outcomes for ulcerative colitis and Crohn’s disease patients. Metaregression was performed for sex and duration of follow-up.

Results

Of the 3119 identified studies, 5 were included in the meta-analysis. A total of 34,977 IBD patients with COVID-19 and 53,270 IBD patients without recorded COVID-19 infection were identified. Two of the studies showed a high risk of bias. The random effects model did not show a statistically significant increase in the risk of adverse IBD outcomes following COVID infection (HR:1.05 [0.75–1.46]). There was no significant difference in adverse outcomes between Crohn’s disease (HR: 0.91 [0.82–1.02]) and ulcerative colitis patients (HR: 0.83 [0.76–0.90]). Neither the proportion of male participants nor the mean duration of follow-up were found to be significant predictors of effect size.

Conclusion

In this systematic review and meta-analysis, we find that COVID-19 did not increase the risk of adverse IBD outcomes.
{"title":"A Systematic Review and Meta-Analysis: Adverse Inflammatory Bowel Disease Outcomes Following Acute COVID-19","authors":"Evangelin Shaloom Vitus ,&nbsp;Simran Mann ,&nbsp;Charlie W. Lees ,&nbsp;Tine Jess ,&nbsp;Rahma Elmahdi","doi":"10.1016/j.gastha.2024.10.021","DOIUrl":"10.1016/j.gastha.2024.10.021","url":null,"abstract":"<div><h3>Background and Aims</h3><div>Respiratory viral infections have been implicated in the exacerbation of immune-mediated inflammatory diseases such as inflammatory bowel disease (IBD). To understand the impact of early SARS-CoV-2 variants on the risk of adverse IBD outcomes, we aimed to perform a meta-analysis of high-quality studies.</div></div><div><h3>Methods</h3><div>Cohort studies investigating adverse IBD outcomes (IBD flares, change in disease activity, change in medication, IBD-related hospitalization, and surgery) following COVID-19 were retrieved from MEDLINE and Embase. The Risk Of Bias In Nonrandomized Studies—of Exposure tool was used to assess risk of bias. Random effects model meta-analysis was used to calculate the hazard ratio (HR) for risk of adverse outcomes. Subgroup analysis was performed to estimate risk of outcomes for ulcerative colitis and Crohn’s disease patients. Metaregression was performed for sex and duration of follow-up.</div></div><div><h3>Results</h3><div>Of the 3119 identified studies, 5 were included in the meta-analysis. A total of 34,977 IBD patients with COVID-19 and 53,270 IBD patients without recorded COVID-19 infection were identified. Two of the studies showed a high risk of bias. The random effects model did not show a statistically significant increase in the risk of adverse IBD outcomes following COVID infection (HR:1.05 [0.75–1.46]). There was no significant difference in adverse outcomes between Crohn’s disease (HR: 0.91 [0.82–1.02]) and ulcerative colitis patients (HR: 0.83 [0.76–0.90]). Neither the proportion of male participants nor the mean duration of follow-up were found to be significant predictors of effect size.</div></div><div><h3>Conclusion</h3><div>In this systematic review and meta-analysis, we find that COVID-19 did not increase the risk of adverse IBD outcomes.</div></div>","PeriodicalId":73130,"journal":{"name":"Gastro hep advances","volume":"4 3","pages":"Article 100581"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143167339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cover: Selective Epithelial Caspase-4 Expression During Colorectal Dysplasia and Carcinoma
Pub Date : 2025-01-01 DOI: 10.1016/S2772-5723(25)00018-4
{"title":"Cover: Selective Epithelial Caspase-4 Expression During Colorectal Dysplasia and Carcinoma","authors":"","doi":"10.1016/S2772-5723(25)00018-4","DOIUrl":"10.1016/S2772-5723(25)00018-4","url":null,"abstract":"","PeriodicalId":73130,"journal":{"name":"Gastro hep advances","volume":"4 2","pages":"Article 100631"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143437232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Incidental Discovery of Duodenal Kaposi Sarcoma
Pub Date : 2025-01-01 DOI: 10.1016/j.gastha.2024.100598
Rangesh Modi , David Hakimian , Edwin McDonald
{"title":"Incidental Discovery of Duodenal Kaposi Sarcoma","authors":"Rangesh Modi ,&nbsp;David Hakimian ,&nbsp;Edwin McDonald","doi":"10.1016/j.gastha.2024.100598","DOIUrl":"10.1016/j.gastha.2024.100598","url":null,"abstract":"","PeriodicalId":73130,"journal":{"name":"Gastro hep advances","volume":"4 4","pages":"Article 100598"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143237941","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Duodenal Organoids From Metabolic Dysfunction-Associated Steatohepatitis Patients Exhibit Absorptive and Barrier Alterations
Pub Date : 2025-01-01 DOI: 10.1016/j.gastha.2024.100599
Alia Hadefi , Morgane Leprovots , Gilles Dinsart , Maryam Marefati , Marjorie Vermeersch , Daniel Monteyne , David Pérez-Morga , Anne Lefort , Frédérick Libert , Laurine Verset , Claire Liefferinckx , Christophe Moreno , Jacques Devière , Eric Trépo , Marie-Isabelle Garcia

Background and Aims

Metabolic dysfunction-associated steatohepatitis (MASH) is a progressive liver disease that can lead to fibrosis, cirrhosis, and hepatocellular carcinoma. Though MASH is closely tied to metabolic risk factors, the underlying pathogenic mechanisms remain scarcely understood. Recent research has emphasized the importance of the gut-liver axis in its pathogenesis, an aspect less explored in human studies. Here, we investigated whether the duodenal epithelium of MASH patients could exhibit intrinsic dysfunctions.

Methods

Duodenal epithelial organoids were generated from 16 MASH patients and 14 healthy controls. Biopsies and patient-derived organoid transcriptomes were then analyzed to evaluate if specific intestinal pathways were differentially modulated in MASH subjects. Functional assays were performed to assess the duodenal epithelial absorptive potential and barrier functionality.

Results

Organoid formation efficiency was similar between control-derived duodenal epithelial organoids and MASH-derived duodenal epithelial organoids (MDEOs) (71% and 69%, respectively). Despite global heterogeneity in growth patterns, MDEOs frequently exhibited cystic spheroid morphology. MDEOs displayed altered digestive potential associated with reduced mature absorptive cell fate, but they retained their lipid metabolic capacity, possibly mediated by lipid oxidation in stem/progenitor cells. Additionally, MDEOs misexpressed components of tight and adherens junctions and desmosomes compared to controls. However, MDEOs maintained pore and leak pathway integrity, indicating that the duodenal epithelial barrier remained functionally preserved under tested conditions.

Conclusion

This study provides evidence that the duodenal epithelium of MASH patients exhibits significant alterations in its nutrition-related and barrier functions. This study sheds light on the intricate dynamics of duodenal epithelial alterations in MASH, highlighting potential therapeutic avenues for restoring intestinal functions.
{"title":"Duodenal Organoids From Metabolic Dysfunction-Associated Steatohepatitis Patients Exhibit Absorptive and Barrier Alterations","authors":"Alia Hadefi ,&nbsp;Morgane Leprovots ,&nbsp;Gilles Dinsart ,&nbsp;Maryam Marefati ,&nbsp;Marjorie Vermeersch ,&nbsp;Daniel Monteyne ,&nbsp;David Pérez-Morga ,&nbsp;Anne Lefort ,&nbsp;Frédérick Libert ,&nbsp;Laurine Verset ,&nbsp;Claire Liefferinckx ,&nbsp;Christophe Moreno ,&nbsp;Jacques Devière ,&nbsp;Eric Trépo ,&nbsp;Marie-Isabelle Garcia","doi":"10.1016/j.gastha.2024.100599","DOIUrl":"10.1016/j.gastha.2024.100599","url":null,"abstract":"<div><h3>Background and Aims</h3><div>Metabolic dysfunction-associated steatohepatitis (MASH) is a progressive liver disease that can lead to fibrosis, cirrhosis, and hepatocellular carcinoma. Though MASH is closely tied to metabolic risk factors, the underlying pathogenic mechanisms remain scarcely understood. Recent research has emphasized the importance of the gut-liver axis in its pathogenesis, an aspect less explored in human studies. Here, we investigated whether the duodenal epithelium of MASH patients could exhibit intrinsic dysfunctions.</div></div><div><h3>Methods</h3><div>Duodenal epithelial organoids were generated from 16 MASH patients and 14 healthy controls. Biopsies and patient-derived organoid transcriptomes were then analyzed to evaluate if specific intestinal pathways were differentially modulated in MASH subjects. Functional assays were performed to assess the duodenal epithelial absorptive potential and barrier functionality.</div></div><div><h3>Results</h3><div>Organoid formation efficiency was similar between control-derived duodenal epithelial organoids and MASH-derived duodenal epithelial organoids (MDEOs) (71% and 69%, respectively). Despite global heterogeneity in growth patterns, MDEOs frequently exhibited cystic spheroid morphology. MDEOs displayed altered digestive potential associated with reduced mature absorptive cell fate, but they retained their lipid metabolic capacity, possibly mediated by lipid oxidation in stem/progenitor cells. Additionally, MDEOs misexpressed components of tight and adherens junctions and desmosomes compared to controls. However, MDEOs maintained pore and leak pathway integrity, indicating that the duodenal epithelial barrier remained functionally preserved under tested conditions.</div></div><div><h3>Conclusion</h3><div>This study provides evidence that the duodenal epithelium of MASH patients exhibits significant alterations in its nutrition-related and barrier functions. This study sheds light on the intricate dynamics of duodenal epithelial alterations in MASH, highlighting potential therapeutic avenues for restoring intestinal functions.</div></div>","PeriodicalId":73130,"journal":{"name":"Gastro hep advances","volume":"4 4","pages":"Article 100599"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143350701","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recipients of Early Liver Transplants for Alcohol-Related Liver Disease May Reside in Areas With Lower Social Vulnerability 酒精相关性肝病的早期肝移植接受者可能居住在社会脆弱性较低的地区。
Pub Date : 2025-01-01 DOI: 10.1016/j.gastha.2024.08.020
James Flanary , Elizabeth A. King , FNU Baimaji , Alexandra T. Strauss , Nicole Welch , Annette Bellar , Courtney B. Sherman , Bilal Hameed , Mandana Khalili , Srinivasan Dasarathy , Andrew M. Cameron , Po-Hung Chen
{"title":"Recipients of Early Liver Transplants for Alcohol-Related Liver Disease May Reside in Areas With Lower Social Vulnerability","authors":"James Flanary ,&nbsp;Elizabeth A. King ,&nbsp;FNU Baimaji ,&nbsp;Alexandra T. Strauss ,&nbsp;Nicole Welch ,&nbsp;Annette Bellar ,&nbsp;Courtney B. Sherman ,&nbsp;Bilal Hameed ,&nbsp;Mandana Khalili ,&nbsp;Srinivasan Dasarathy ,&nbsp;Andrew M. Cameron ,&nbsp;Po-Hung Chen","doi":"10.1016/j.gastha.2024.08.020","DOIUrl":"10.1016/j.gastha.2024.08.020","url":null,"abstract":"","PeriodicalId":73130,"journal":{"name":"Gastro hep advances","volume":"4 1","pages":"Article 100542"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11719348/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142973645","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hematemesis as a Result of Hepatic Arterioportal Fistula Formation
Pub Date : 2025-01-01 DOI: 10.1016/j.gastha.2024.10.019
Hannah Zuercher , Juan Gonzalez , Andreas Zori
{"title":"Hematemesis as a Result of Hepatic Arterioportal Fistula Formation","authors":"Hannah Zuercher ,&nbsp;Juan Gonzalez ,&nbsp;Andreas Zori","doi":"10.1016/j.gastha.2024.10.019","DOIUrl":"10.1016/j.gastha.2024.10.019","url":null,"abstract":"","PeriodicalId":73130,"journal":{"name":"Gastro hep advances","volume":"4 3","pages":"Article 100579"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11786882/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143082135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Histological Findings of Hypervitaminosis A Liver Disease A型维生素过多症肝病的组织学表现。
Pub Date : 2025-01-01 DOI: 10.1016/j.gastha.2024.08.010
Richard H. Goodheart , Dilini Gunawardena , Adam Doyle
{"title":"Histological Findings of Hypervitaminosis A Liver Disease","authors":"Richard H. Goodheart ,&nbsp;Dilini Gunawardena ,&nbsp;Adam Doyle","doi":"10.1016/j.gastha.2024.08.010","DOIUrl":"10.1016/j.gastha.2024.08.010","url":null,"abstract":"","PeriodicalId":73130,"journal":{"name":"Gastro hep advances","volume":"4 1","pages":"Article 100531"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11713470/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142959693","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The immune inductive role of hepatic arterial infusion chemotherapy prior to atezolizumab plus bevacizumab combination therapy in hepatocellular carcinoma 肝细胞癌阿特珠单抗加贝伐单抗联合治疗前的肝动脉灌注化疗的免疫诱导作用
Pub Date : 2024-02-01 DOI: 10.1016/j.gastha.2024.01.013
Hiroyuki Suzuki, Miwa Sakai, H. Iwamoto, S. Shimose, T. Niizeki, M. Nakano, T. Shirono, Y. Noda, Etsuko Moriyama, R. Kuromatsu, H. Koga, Takumi Kawaguchi
{"title":"The immune inductive role of hepatic arterial infusion chemotherapy prior to atezolizumab plus bevacizumab combination therapy in hepatocellular carcinoma","authors":"Hiroyuki Suzuki, Miwa Sakai, H. Iwamoto, S. Shimose, T. Niizeki, M. Nakano, T. Shirono, Y. Noda, Etsuko Moriyama, R. Kuromatsu, H. Koga, Takumi Kawaguchi","doi":"10.1016/j.gastha.2024.01.013","DOIUrl":"https://doi.org/10.1016/j.gastha.2024.01.013","url":null,"abstract":"","PeriodicalId":73130,"journal":{"name":"Gastro hep advances","volume":"135 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139816822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Using a Population Database to Assess Lifestyle Factors in Serrated Polyposis Syndrome and Sporadic Sessile Serrated Lesions. 利用人口数据库评估锯齿状息肉病综合征和零星无锯齿状病变的生活方式因素。
Pub Date : 2024-02-01 DOI: 10.1016/j.gastha.2024.01.014
Karen Curtin, Michael J. Madsen, Zhe Yu, Priyanka Kanth
{"title":"Using a Population Database to Assess Lifestyle Factors in Serrated Polyposis Syndrome and Sporadic Sessile Serrated Lesions.","authors":"Karen Curtin, Michael J. Madsen, Zhe Yu, Priyanka Kanth","doi":"10.1016/j.gastha.2024.01.014","DOIUrl":"https://doi.org/10.1016/j.gastha.2024.01.014","url":null,"abstract":"","PeriodicalId":73130,"journal":{"name":"Gastro hep advances","volume":"26 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139871457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Image of the Month Penile metastasis from esophageal squamous cell cancer. 本月图片 食管鳞状细胞癌的阴茎转移。
Pub Date : 2024-02-01 DOI: 10.1016/j.gastha.2024.02.001
Naoki Hayata, Norio Araki, Shin’ichi Miyamoto
{"title":"Image of the Month Penile metastasis from esophageal squamous cell cancer.","authors":"Naoki Hayata, Norio Araki, Shin’ichi Miyamoto","doi":"10.1016/j.gastha.2024.02.001","DOIUrl":"https://doi.org/10.1016/j.gastha.2024.02.001","url":null,"abstract":"","PeriodicalId":73130,"journal":{"name":"Gastro hep advances","volume":"129 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139827522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Gastro hep advances
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1